Legal Representation
Attorney
Mark Farrell
USPTO Deadlines
Next Deadline
836 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220503)
Due Date
May 03, 2028
Grace Period Ends
November 03, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 3, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 29, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Mar 28, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Mar 4, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 3, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jan 24, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Mar 3, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 12, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 1, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 25, 2022 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Jan 24, 2022 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Jan 24, 2022 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jan 24, 2022 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jan 24, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 13, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 13, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 11, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 16, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 16, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 24, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 5, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 29, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 29, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 22, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 28, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 28, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for boosting the body's immune system, and for preventing and counteracting the cytokine storm as seen in infections with SARS-CoV-2 and other viral infections, consisting of a synergistic and specialized combination of certain plants in tablet, capsule or liquid dosage form for oral administration; Pharmaceutical preparations, namely, antivirals; Therapeutic pharmaceutical for the treatment of cytokine storm as seen in infections with SARS-CoV-2 and other viral and other infections
First Use Anywhere:
Aug 25, 2020
First Use in Commerce:
Mar 1, 2021
Additional Information
Pseudo Mark
ARTOVID-TWENTY; ARTOVID-TWO ZERO
Classification
International Classes
005